EODData

MEMBERSHIP REGISTER LOG IN

SWX, LONN: Lonza Group AG

18 May 2026
LAST:

468.3

CHANGE:
 12.60		OPEN:
464.8		HIGH:
472.1		ASK:
0.0		VOLUME:
151.6K
CHG(%):
2.27		PREV:
554.4		LOW:
463.0		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
18 May 26464.8472.1463.0468.3151.6K
15 May 26474.9477.5466.3469.4161.5K
13 May 26478.1478.9471.6474.2144.4K
12 May 26472.3484.2472.2478.1113.8K
11 May 26486.0487.7480.6481.8138.3K
08 May 26486.4491.8472.6483.0234.7K
07 May 26494.7496.0485.6486.2187.1K
06 May 26497.1502.0492.0493.6173.7K
05 May 26479.0494.4479.0490.2217.6K
04 May 26484.0484.2471.6479.2213.0K

PROFILE

Name:Lonza Group AG
About:Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. Its Small Molecules segment provides integrated development and manufacturing services for small molecule drug substances and their intermediates. This segment also supports customers across aspects of design, development, and manufacturing, such as particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. Its Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Sector:Healthcare
Address:Muenchensteinerstrasse 38, Basel, Switzerland, 4002
Website:https://www.lonza.com
ISIN:CH0013841017
FIGI:BBG000NQXR55
LEI:549300EFW4H2TCZ71055

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:39.37 
Forward P/E:23.57 
PEG Ratio:26.97 
Price to Sales:5.27 
Price to Book:3.93 
Profit Margin:0.10 
Operating Margin:0.17 
Return on Assets:0.04 
Return on Equity:0.08 
EPS Ratio:13.01 
DivYield:0.01 
Div/Share:4.00 
Revenue:7.093B 
EBITDA:1.607B 
Shares:69.84M 
Market Cap:32.708B 

RECENT DIVIDENDS

Date Amount
12 May 2026$5.00
13 May 2025$4.00
13 May 2024$4.00
09 May 2023$3.50
09 May 2022$3.00
10 May 2021$3.00
30 Apr 2020$2.75
24 Apr 2019$2.75
07 May 2018$2.75
26 Apr 2016$2.32